Medtronic (MDT) – Company Press Releases
-
Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity
-
Americans favor quality over quantity in pursuit of longevity
-
Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care
-
Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care
-
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
-
The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation
-
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
-
New survey uncovers lack of awareness around heart valve disease and risk factors among women
-
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
-
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market Growth
-
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
-
U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents
-
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
-
New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management
-
Medtronic announces cash dividend for fourth quarter of fiscal year 2024
-
Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference
-
Medtronic Once Again Named One of the World's Most Ethical Companies
-
Medtronic files ITC action against Axonics to stop unauthorized use of Medtronic innovations
-
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over
-
Medtronic reports third quarter fiscal 2024 financial results
-
Medtronic to announce financial results for its third quarter of fiscal year 2024
-
Medtronic LABS President Ruchika Singhal Named “Corporate Social Innovator of the Year” by Schwab Foundation
-
FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology
-
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients
-
Medtronic Diabetes announces world's first approval for MiniMed™ 780G System with Simplera Sync™ disposable, all-in-one sensor
-
Medtronic receives CE Mark for its next generation Micra leadless pacing systems
-
Hypertension Control Program Aims to Tackle Major Driver of Health Disparities for Black Americans
-
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
-
Medtronic Continues To Rank in the DJSI World Index for 2023
-
Medtronic creates history with FDA approval of its novel PulseSelect™ Pulsed Field Ablation System to treat atrial fibrillation
-
Cosmo Pharmaceuticals and Medtronic Forge Ahead in AI-Driven Care
-
Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care
-
Medtronic announces cash dividend for third quarter of fiscal year 2024
-
Medtronic reports second quarter fiscal 2024 financial results
-
Medtronic announces FDA approval of minimally invasive device to treat hypertension
-
Medtronic: A Majority of Americans Are Optimistic That AI Will Improve Healthcare in 2024
-
A majority of Americans are optimistic that AI will improve healthcare in 2024
-
Medtronic to announce financial results for its second quarter of fiscal year 2024
-
Medtronic Evolut™ TAVR platform outperforms surgery with sustained valve performance for low-risk patients at four years
-
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
-
Medtronic Named to 100 Best Corporate Citizens of 2023
-
TMCF and Medtronic Partner To Launch Academic R&D Grants at HBCUs
-
Gentherm Announces Dr. Ken Washington as New Independent Director
-
Medtronic Diabetes announces CE Mark for new Simplera™ CGM with disposable all-in-one design
-
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients
-
Medtronic receives CE Mark approval for Inceptiv™ spinal cord stimulator with closed-loop sensing to treat chronic pain
-
Medtronic issues statement on the FDA Circulatory Systems Devices Advisory Panel vote for the Symplicity Spyral Renal Denervation System
-
Medtronic to participate in upcoming investor conferences
-
Medtronic reports first quarter fiscal 2024 financial results
-
Medtronic announces cash dividend for second quarter of fiscal year 2024
Back to MDT Stock Lookup
